Movement Disorders News

Nov 28, 2017
Low frequency brain stimulation improves cognition in Parkinson disease
Rare intraoperative brain recordings identify new brain connection that may be a target for improving cognitive symptoms in Parkinson disease.
Nov 06, 2017
Depressed with a chronic disease? Consider alternative therapies
Scientists find that commonly prescribed antidepressants aren't effective in people battling both depression and a chronic medical disease, raising a critical question of whether doctors should enact widespread changes in how they treat millions of depressed Americans.
Sep 13, 2017
Systems analysis points to links between Toxoplasma infection and common brain diseases
Infection with Toxoplasma gondii may alter, and in some cases amplify, several brain disorders, including epilepsy, Alzheimer and Parkinson diseases as well as some cancers.
Aug 31, 2017
FDA Approves AUSTEDO® (deutetrabenazine) Tablets for the Treatment of Tardive Dyskinesia in Adults
AUSTEDO® is the first and only FDA-approved product to treat both tardive dyskinesia in adults and chorea associated with Huntington disease.
Aug 28, 2017
FDA Approves Treatment for Levodopa-Related Dyskinesia in Parkinson Disease
US Food and Drug Administration approves extended-release amantadine capsules (GOCOVRI™) for the treatment of dyskinesia in people with Parkinson disease receiving levodopa-based therapy.
Jul 27, 2017
Immune system may mount an attack in Parkinson disease
Study suggests that T cells, which help the body's immune system recognize friend from foe, may play an important role in Parkinson disease.
Jun 27, 2017
Transcranial stimulation and/or physical therapy improves walking speed in Parkinson disease
Transcranial direct current stimulation and physical therapy could be used alone or in combination to improve walking speed and step length in patients with Parkinson disease according to a study published in the American Journal of Physical Medicine & Rehabilitation.
Jun 21, 2017
Researchers uncover genetic gains and losses in Tourette syndrome
Researchers have identified structural changes in 2 genes that increase the risk of developing Tourette syndrome. These were deletions in the NRXN1 gene or duplications in the CNTN6 gene. The study is published in the journal Neuron.
Jun 20, 2017
Genetic modifier for Huntington disease progression identified
A team of researchers has developed a novel measure of disease progression for Huntington disease, which enabled them to identify a genetic modifier associated with how rapidly the disease progresses -- MSH3. The study was reported in Lancet Neurology.
May 15, 2017
Neurosurgeons perform focused ultrasound treatment for essential tremor
MR-guided focused ultrasound treatment, now FDA approved, has great promise as a non-invasive treatment for essential tremor. In this instance, the patient is now tremor-free in his right hand post-procedure, after 10 years of suffering from bilateral essential tremor.
Next ▶